# John C. Lieske, M.D., Clinical Investigator – FDA Inspection, Mar 3, 2023

Source: https://www.keypedia.com/records/fda_inspections/john-c-lieske-md-clinical-investigator/94e1fecd-15a3-4b70-be3c-83133afffb6a
Source feed: FDA_Inspections

> FDA inspection 1199188 of John C. Lieske, M.D., Clinical Investigator, March 03, 2023. Classification: No Action Indicated (NAI). 2 citations under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1199188
- Company Name: John C. Lieske, M.D., Clinical Investigator
- Inspection Date: 2023-03-03
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/sharon-l-matson/1d2e6d91-1d00-455d-a2e6-a73b1c6b82cc)

Company: https://www.keypedia.com/companies/john-c-lieske-md-clinical-investigator/e685fd45-bb44-46af-b8a1-9cc21deb7042

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
